Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC14B | O60729 | 2/20 | 0.50 |
| ▸ | CDC14A | Q9UNH5 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.40 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.40 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.40 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | CSF1R | P07333 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18382847 | 0.98 | CDC14B (0.49) | CDC14BCDC14ACA1CA2CYP19A1 | |
| SCHEMBL26404172 | 0.98 | CDC14B (0.49) | CDC14BCDC14ACA1CA2CYP19A1 | |
| SCHEMBL17917499 | 0.98 | CDC14B (0.51) | CDC14BCDC14ACA1CA2CYP19A1 | |
| SCHEMBL18382914 | 0.95 | CDC14B (0.51) | CDC14BCDC14ACA1CA2CYP19A1 | |
| SCHEMBL25871310 | 0.93 | CDC14B (0.46) | CDC14BCDC14ACA1CA2CYP19A1 | |
| SCHEMBL23504692 | 0.93 | CDC14B (0.45) | CDC14BCDC14ACA1CA2CYP19A1 | |
| SCHEMBL21579235 | 0.93 | CDC14B (0.45) | CDC14BCDC14ACA1CA2CYP19A1 | |
| SCHEMBL23504682 | 0.93 | ALOX5 (0.51) | CDC14BCDC14ACA1CA2CYP19A1 | |
| SCHEMBL19764781 | 0.92 | CDC14B (0.49) | CDC14BCDC14ACA1CA2CYP19A1 | |
| SCHEMBL21131636 | 0.92 | CDC14B (0.46) | CDC14BCDC14ACA1CA2CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11365167-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2022-06-21 | — | — | US | disclosed |
| US-20210053894-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2021-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210053894-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | L1CAM, EFNA1, EPCAM | CDC14B 4597/4885CDC14A 4518/4885CA1 1105/4885 |
| US-11365167-B2 | Materials for organic electroluminescent devices | L1CAM, EFNA1, EPCAM | CDC14B 4597/4885CDC14A 4518/4885CA1 1105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.